| http://www.w3.org/ns/prov#value | - BEVERLY, MA--(Marketwire - June 22, 2012) - Cellceutix Corporation (OTCBB: CTIX) (the Company), a biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases, is pleased to announce that the U.S. Food and Drug Administration (FDA) has completed the review of the Company's Investigational New D
|
